Institutional & Family Asset Management, LLC Karuna Therapeutics, Inc. Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$176.32 - $240.22 $352 - $480	-2 Reduced 66.67%	1 $0
Q2 2022 Aug 08, 2022	SELL	$93.97 - $143.33 $281 - $429	-3 Reduced 50.0%	3 $0
Q1 2022 May 11, 2022	BUY	$98.9 - $132.37 $98 - $132	1 Added 20.0%	6 $1,000
Q3 2021 Nov 10, 2021	SELL	$101.2 - $125.87 $404 - $503	-4 Reduced 44.44%	5 $1,000
Q1 2021 May 06, 2021	SELL	$95.46 - $133.08 $572 - $798	-6 Reduced 40.0%	9 $1,000
Q4 2020 Feb 03, 2021	SELL	$75.23 - $109.23 $75 - $109	-1 Reduced 6.25%	15 $2,000
Q2 2020 Aug 14, 2020	BUY	$62.14 - $117.21 $124 - $234	2 Added 14.29%	16 $2,000
Q1 2020 May 14, 2020	BUY	$60.41 - $115.92 $845 - $1,622	14 New	14 $1,000

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account